Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (21-30 of 192) with videos related to

Pageof 20
Sort By:
Oncology Letters|June 25, 2014
Important factors for achieving survival of five years or more in non-small cell lung cancer patients with distant metastasisTomonori Hirashima, Hidekazu Suzuki, Norio Okamoto, et al.
Anticancer Research|April 12, 2012
Long-term amrubicin chemotherapy for small-cell lung cancerMasayoshi Higashiguchi, Hidekazu Suzuki, Tomonori Hirashima, et al.
Investigational New Drugs|March 15, 2018
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancerMotohiro Tamiya, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Respiratory Medicine Case Reports|March 1, 2018
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinomaShingo Satoh, Takayuki Shiroyama, Motohiro Tamiya, et al.
Chinese Journal of Cancer|December 15, 2012
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutationsHidekazu Suzuki, Tomonori Hirashima, Norio Okamoto, et al.
Medicine|May 5, 2022
Manual route modification using an oblique method following automatic virtual bronchoscopic navigationTakako Inoue, Takahisa Kawamura, Kei Kunimasa, et al.
Medical Oncology (Northwood, London, England)|January 25, 2011
Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancerMotohiro Tamiya, Hidekazu Suzuki, Masashi Kobayashi, et al.
Journal of Thoracic Disease|February 24, 2016
Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapyManabu Hayama, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Respiratory Medicine Case Reports|April 30, 2020
Infectious pericarditis caused by <i>Gemella sanguinis</i> induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case reportTakako Inoue, Tatsuya Nishikawa, Kei Kunimasa, et al.
Asia-Pacific Journal of Clinical Oncology|December 23, 2016
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapyMotohiro Tamiya, Takayuki Shiroyama, Takashi Nishihara, et al.
Pageof 20

Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Oncology Letters|June 25, 2014
Important factors for achieving survival of five years or more in non-small cell lung cancer patients with distant metastasisTomonori Hirashima, Hidekazu Suzuki, Norio Okamoto, et al.
Anticancer Research|April 12, 2012
Long-term amrubicin chemotherapy for small-cell lung cancerMasayoshi Higashiguchi, Hidekazu Suzuki, Tomonori Hirashima, et al.
Investigational New Drugs|March 15, 2018
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancerMotohiro Tamiya, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Respiratory Medicine Case Reports|March 1, 2018
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinomaShingo Satoh, Takayuki Shiroyama, Motohiro Tamiya, et al.
Chinese Journal of Cancer|December 15, 2012
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutationsHidekazu Suzuki, Tomonori Hirashima, Norio Okamoto, et al.
Medicine|May 5, 2022
Manual route modification using an oblique method following automatic virtual bronchoscopic navigationTakako Inoue, Takahisa Kawamura, Kei Kunimasa, et al.
Medical Oncology (Northwood, London, England)|January 25, 2011
Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancerMotohiro Tamiya, Hidekazu Suzuki, Masashi Kobayashi, et al.
Journal of Thoracic Disease|February 24, 2016
Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapyManabu Hayama, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Respiratory Medicine Case Reports|April 30, 2020
Infectious pericarditis caused by <i>Gemella sanguinis</i> induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case reportTakako Inoue, Tatsuya Nishikawa, Kei Kunimasa, et al.
Asia-Pacific Journal of Clinical Oncology|December 23, 2016
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapyMotohiro Tamiya, Takayuki Shiroyama, Takashi Nishihara, et al.
Pageof 20